A Study to Learn About How Elinzanetant Works and How Safe it is in Women Having Sleep Disturbances Associated With Menopause
Clinical trial NCT06112756 · COMPLETED
Trial details
- NCT number
- NCT06112756
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-08
- Primary completion
- 2024-08-22
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.